Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Darwin Global Management, Ltd. (CIK 1839209) reported $3.77B across 6 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: INSM ($2.58B, 68.33%), BLTE ($456.1M, 12.10%), ABVX ($352.1M, 9.34%), RVMD ($205.0M, 5.44%), ROIV ($179.5M, 4.76%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | INSM | INSMED INC | $2.58B | 68.33% | 16.8M | Trimmed |
| 2 | BLTE | BELITE BIO INC | $456.1M | 12.10% | 3.1M | Added |
| 3 | ABVX | ABIVAX SA | $352.1M | 9.34% | 3.5M | Added |
| 4 | RVMD | REVOLUTION MEDICINES INC | $205.0M | 5.44% | 2.2M | New |
| 5 | ROIV | ROIVANT SCIENCES LTD | $179.5M | 4.76% | 6.8M | New |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $1.5M | 0.04% | 17,357 | New |
| 7 | CAPR | CAPRICOR THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 8 | CDTX | CIDARA THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 9 | WVE | WAVE LIFE SCIENCES LTD | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31